Irina Erenburg, PhD
President & CEO
Dr. Irina Erenburg is a successful serial entrepreneur with extensive experience in innovation business leadership. She was previously Director of Strategic Transactions at the Partners HealthCare Office of Innovations, Boston’s largest hospital network and a teaching affiliate of Harvard University, and was responsible for high-value deals and startups at MGH — including Zeltiq Aesthetics, which was later acquired by Allergan for $2.4B. She is a co-founder and board member at R2 Dermatology, Inc., and Soltego, Inc., and serves as CEO of AVAVA, Inc.